Company Filing History:
Years Active: 2011
Title: Andrew Vincent Trask: Innovator in Pharmaceutical Chemistry
Introduction
Andrew Vincent Trask is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on imidazole derivatives. His expertise and dedication to research have led to the development of valuable patents that advance medical science.
Latest Patents
Trask holds a patent for "Crystal forms of an imidazole derivative." This invention relates to the essentially pure β/-[({2-[4-(2-Ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl}amino)carbonyl]-4-methylbenzenesulfonamide Polymorph Forms A and B. The patent also covers processes for the preparation of these forms, compositions containing them, and their various uses.
Career Highlights
Trask is associated with Requalia Pharma Inc., where he applies his knowledge and skills to develop innovative pharmaceutical solutions. His work has been instrumental in advancing the company's research initiatives and product development.
Collaborations
Throughout his career, Trask has collaborated with talented professionals, including Naoaki Haruta and Tomoki Kato. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Andrew Vincent Trask is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. His contributions, particularly in the development of imidazole derivatives, showcase his commitment to innovation and excellence.